No publications last week or this week. I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!
economics
New publications in health economics and genomics 22nd September 2020
Three publications from the past week:
- A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis | link
- Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology | link
- Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients | link
I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!
New publications in health economics and genomics 8th September 2020
Two publications from the last week:
- Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency | link
- Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 1st September 2020
One publication from the last week:
- The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 25th August 2020
Two publications from the last week:
- Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia | link
- Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 18th August 2020
Two publications from the last week:
- Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment | link
- A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 11th August 2020
Two publications from the last two weeks:
- Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer | link
- PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 21st July 2020
One publication this week:
- Next generation use in Oncology, a better information on patients’ genetic profiles improved access to matched treatments and earlier NGS use show better outcomes | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 14th July 2020
Three publications this week:
- PARC report: health outcomes and value of personalized medicine interventions: impact on patient care | link
- The Daunting Economics of Therapeutic Genome Editing | link
- Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.
New publications in health economics and genomics 7th July 2020
No publications last week, but five (well, kind of) this week:
- Costs of In-House Genomic Profiling and Implications for Economic Evaluation: A Case Example of Non-Small Cell Lung Cancer (NSCLC) | link
- Multi-gene Assays: Effect on Chemotherapy Use, Toxicity and Cost in Estrogen Receptor-Positive Early Stage Breast Cancer | link
- Ending the Diagnostic Odyssey—Is Whole-Genome Sequencing the Answer? | link
- Economic Value of Exome Sequencing for Suspected Monogenic Disorders [letter] | link
- Response to Ferket Et Al [response to letter] | link
I’m happy to share any other publications from this week that I’ve missed – just let me know.